ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

NCI’s New Policy On Costly Research

December 10, 1993

Cure For Lymphoma Foundation Awards Five; Lefall Honored; AACR Begins New Journal.

November 23, 2001

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Bush Proposes 16 Percent Increase For NIH, To Complete Budget Doubling.

February 1, 2002